Working Hours

Mon - Sat 10:00 - 6:30
Mito 10 mg Mitomycin Injection I.P
Mito 10 mg Mitomycin Injection I.P

Mito 10 mg Mitomycin Injection I.P

Price 650 INR/ Vial

MOQ : 10 Vials

Mito 10 mg Mitomycin Injection I.P Specification

  • Salt Composition
  • Mitomycin 10 mg
  • Dosage Form
  • Injection
  • Pacakaging (Quantity Per Box)
  • 1 vial per box
  • Packaging Type
  • Vial & carton box
  • Life Span
  • 36 months
  • Indication
  • Cancer treatment
  • Origin of Medicine
  • India
  • Drug Type
  • Other
  • Ingredients
  • Mitomycin
  • Physical Form
  • Other
  • Function
  • Other
  • Recommended For
  • Antineoplastic therapy
  • Dosage
  • 10 mg
  • Dosage Guidelines
  • As directed by physician
  • Suitable For
  • Adults
  • Quantity
  • 1 Vial Unit
  • Storage Instructions
  • Store below 25C
  • Single-use
  • Yes
  • Colour of Box
  • White and purple
  • Presentation
  • Powder vial
  • Pharmacopoeia Standard
  • IP
  • Prescription Required
  • Yes
  • Administration Route
  • Intravenous
  • Container Seal
  • Green cap
  • Strength
  • 10 mg
 

Mito 10 mg Mitomycin Injection I.P Trade Information

  • Minimum Order Quantity
  • 10 Vials
  • Payment Terms
  • Cash in Advance (CID)
  • Supply Ability
  • 500 Vials Per Month
  • Delivery Time
  • 7 Days
  • Main Domestic Market
  • All India
 

About Mito 10 mg Mitomycin Injection I.P



Ending Soon: Take advantage of this scarce promotional offer on Mito 10 mg Mitomycin Injection I.P, a matchless cytotoxic chemotherapy solution renowned for its stellar efficacy in cancer treatment. This majestic powder vial, sealed with a distinguished green cap and housed in a white and purple box, ensures ultimate safety and easy identification. Each single-use dose aligns with Pharmacopoeia Standard IP and is suited for adult intravenous administration under prescription. With a 36-month life span and original Indian origin, Mito promises dependable results-store below 25C for optimal potency. Act quickly; supplies are limited!

Superior Attributes & Versatile Applications

Mito 10 mg Mitomycin Injection I.P boasts extra features including a robust powder-for-injection formulation for easy reconstitution, sealed green-capped vials ensuring purity, and packaging designed for single-use sterility. While primarily recommended for cancer therapy, it is also valued in the management of various solid tumors, adding versatility to its applications. Mitomycin is administered intravenously, making it ideal for hospital environments, specialty clinics, and oncology treatment centers where precise dosage is essential.


Sample Policy, Order Processing, and Certifications

Our export market extends across continents, ensuring prompt order fulfillment and reliable dispatch after a confirmed purchase order. Samples of Mito 10 mg Mitomycin Injection I.P are available to registered medical institutions; detailed sample policies are provided upon inquiry. Payment terms are highly secure and flexible. The product upholds strict certification protocols, aligning with all key Pharmacopoeia Standards and regulatory compliances to ensure patient safety and healthcare institutional requirements.


FAQ's of Mito 10 mg Mitomycin Injection I.P:


Q: How should Mito 10 mg Mitomycin Injection I.P be stored and for how long is it effective?

A: Store the injection below 25C and protect it from light. It maintains potency for up to 36 months from the manufacturing date when kept under the recommended storage conditions.

Q: What is the recommended administration route and who is it suitable for?

A: Mito 10 mg Mitomycin Injection I.P is designed for intravenous administration and is suitable for adults only, to be used strictly under medical supervision and as prescribed by a physician.

Q: When should Mito 10 mg Mitomycin Injection I.P be used?

A: This medication is indicated for antineoplastic therapy, specifically for cancer treatment and the management of solid tumors, as directed by your healthcare provider.

Q: Where is Mito 10 mg Mitomycin Injection I.P manufactured and what quality standards does it meet?

A: The injection is manufactured in India, adhering to Pharmacopoeia Standard IP and all major regulatory guidelines to ensure matchless quality and patient safety.

Q: What are the benefits of using Mito 10 mg Mitomycin Injection I.P in oncological therapy?

A: Mito offers a matchless cytotoxic effect against cancer cells, providing effective support as part of comprehensive antineoplastic regimens. Its strict packaging and presentation ensure safety and ease of use in medical settings.

Q: How can I procure samples and what is the process for placing an order?

A: Samples are available for registered medical institutions. Orders can be placed via an official purchase order, and products are dispatched following confirmation and payment as per established terms.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Pharmaceuticals Injection Category

Menotropin Hmg 150 Iu Injection

Menotropin Hmg 150 Iu Injection

Price 750 INR / Box

Minimum Order Quantity : 3 Boxes

Suitable For : Adults

Storage Instructions : Store in a cool, dry place

Dosage : 150 IU per vial

Origin of Medicine : India

Renocel 4000 IU Erythropoietin Injection IP

Renocel 4000 IU Erythropoietin Injection IP

Price 190 INR / Box

Minimum Order Quantity : 10 Boxes

Suitable For : Adults

Storage Instructions : Store in refrigerator (2C 8C)

Dosage : 4000 IU

Origin of Medicine : India

Human Albumin 20 100 Ml

Human Albumin 20 100 Ml

Price 4400 INR / Bottle

Minimum Order Quantity : 2 Bottles

Suitable For : Other, Adults and children

Storage Instructions : Store at 28C

Dosage : As prescribed by physician

Origin of Medicine : Human plasma derived

Zoladex 10.8 mg Goserelin Injection

Zoladex 10.8 mg Goserelin Injection

Minimum Order Quantity : 2 Boxes

Suitable For : Adults

Storage Instructions : Store below 25C, protect from light and moisture

Dosage : 10.8 mg

Origin of Medicine : Manufactured by AstraZeneca



Back to top